about
Genomewide association study in cervical dystonia demonstrates possible association with sodium leak channel.Pain in multiple system atrophy and progressive supranuclear palsy compared to Parkinson's disease.Small fiber neuropathy in Parkinson's disease: A clinical, pathological and corneal confocal microscopy studyDystonia Associated with Idiopathic Slow Orthostatic Tremor.Psychosocial therapy for Parkinson's-related dementia: study protocol for the INVEST randomised controlled trial.A European multicentre survey of impulse control behaviours in Parkinson's disease patients treated with short- and long-acting dopamine agonists.King's Parkinson's disease pain scale, the first scale for pain in PD: An international validation.Non-motor symptoms burden in treated and untreated early Parkinson's disease patients: argument for non-motor subtypes.5-HT modulation of pain perception in humans.Indian-subcontinent NBIA: unusual phenotypes, novel PANK2 mutations, and undetermined genetic forms.Pramipexole and gender identity disorder: expanding the phenotype of hypersexuality in Parkinson's disease.Synaptic recruitment of AMPA glutamate receptor subunits in levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate.Striatal cannabinoid CB1 receptor mRNA expression is decreased in the reserpine-treated rat model of Parkinson's disease.Selective blockade of D(3) dopamine receptors enhances the anti-parkinsonian properties of ropinirole and levodopa in the MPTP-lesioned primate.Topiramate reduces levodopa-induced dyskinesia in the MPTP-lesioned marmoset model of Parkinson's disease.Topiramate-responsive cerebellar axial postural tremor.Quality of life outcome after subthalamic stimulation in Parkinson's disease depends on age.Postoperative muscle weakness in a patient recently treated with infliximab.Nonmotor symptoms evolution during 24 months of bilateral subthalamic stimulation in Parkinson's disease.Cerebellar axial postural tremor complicating radiotherapy for prostate cancer.Randomized clinical trial of topiramate for levodopa-induced dyskinesia in Parkinson's disease.The perception of affective touch in Parkinson's disease and its relation to small fibre neuropathy.A detailed clinical study of pain in 1957 participants with early/moderate Parkinson's diseaseShort-term quality of life after subthalamic stimulation depends on non-motor symptoms in Parkinson's diseaseCervical myelopathy secondary to Tourette's syndrome managed by urgent deep brain stimulationReversible pseudoathetosis induced by cervical myelopathyNon-motor symptoms profile and burden in drug naïve versus long-term Parkinson's disease patientsGenome-Wide Association Study of Pain in Parkinson's Disease Implicates TRPM8 as a Risk FactorAtypical late presentation of BPAN in a male: A case reportParkinson's-adapted cognitive stimulation therapy: feasibility and acceptability in Lewy body spectrum disordersProminent Lower-Limb Involvement in a Family with Myoclonus-DystoniaObjective Analysis of Neck Muscle Boundaries for Cervical Dystonia Using Ultrasound Imaging and Deep LearningReal world use of a neurophysiology service for the differential diagnosis of hyperkinetic movement disordersPedunculopontine Nucleus Microstructure Predicts Postural and Gait Symptoms in Parkinson's Disease
P50
Q34398504-A23E4DB0-4969-46F8-A7B5-FD9368439013Q35309591-2BCB9BB1-40EA-48A8-AC43-088CD29C48C6Q36352702-2684A1F9-420B-4143-95DB-021192BCB745Q38349843-CBEB8C42-5C91-411D-AB46-5626A86C34C8Q38718444-DC8BB9D2-F2C7-4594-8FB5-960ED26DCD26Q39773537-B6607117-45E5-4542-ACBC-5DA17945815FQ40814608-806C1BF4-E139-4851-BF9F-F6BA234ABB4BQ40932187-8FD54BEA-DB99-43E2-BA86-23582668FC98Q41456652-6F655ED2-134A-4261-BD15-17C7FE7BB54EQ42970950-02357FE3-B200-4C6A-BF75-841AD9AAAF04Q43248202-6FCA882B-D072-4A67-86CA-7FD00D976330Q43256114-F2B21AC5-9467-447F-ABB1-9BF77EA74C52Q43611998-166F5148-BAC8-43F8-B037-2EAEAE72810FQ44932324-3E21D9BD-01D6-4685-8618-502DF58C080AQ45184312-9807F92D-9706-455C-8A1B-E902895126A4Q46622466-B7D6BF1B-6683-41C6-8B9C-3768A581F1F4Q47963795-581AE799-B547-4546-ACC9-78922F0C877DQ48500167-7B0FAFA4-D285-4265-96F2-8D330927A3E7Q49710521-43D7D781-7AFF-4FD1-8415-3FB53D8E4E03Q50261759-56499243-12EE-459F-9435-E7BFD8625E1BQ50660164-7D0C77F6-C38F-4048-8EC1-351527C7D1F7Q52836578-A584F19F-71A9-4719-9927-E62F7D7E6267Q64866931-829CB86E-BDAA-4F5A-8176-FAA7A53F92ECQ64895740-2224DDE3-0CC4-4812-91C7-DB2E33660252Q87043697-0F439327-0737-44EE-BE57-BDD54B184066Q87355628-02B74B0C-4D5A-4EE4-9E31-E22B1E667B2DQ88076085-A440D516-A1F6-4036-A29E-F84AF5389D51Q89800608-3B8E03F7-DDE0-497F-9747-D49C908874DDQ91471539-048B2E56-20AA-4B4A-99F0-CF96599525D8Q92506366-E4313E32-AA35-46D0-9F7C-39DA56A1A585Q92586785-7D5B0EC9-F21F-4C8D-B646-3B1563D37A11Q92659983-FD6A72E2-C683-4E2E-8DB3-FBA9B43C89A3Q92731634-DAD0A055-1C75-4E33-8325-238849F3DFCCQ94646134-3F3F23BE-7365-46BA-BE3C-CEFD18109BCA
P50
description
researcher ORCID ID = 0000-0002-3295-6897
@en
wetenschapper
@nl
name
Monty Silverdale
@ast
Monty Silverdale
@en
Monty Silverdale
@es
Monty Silverdale
@nl
type
label
Monty Silverdale
@ast
Monty Silverdale
@en
Monty Silverdale
@es
Monty Silverdale
@nl
prefLabel
Monty Silverdale
@ast
Monty Silverdale
@en
Monty Silverdale
@es
Monty Silverdale
@nl
P106
P31
P4012
P496
0000-0002-3295-6897